Nuvation Bio (NUVB) Stock Price, Quote, News & History | Benzinga

SPY—QQQ—BTC/USD—DIA—GLD—TLT—

Nuvation Bio Inc (NUVB) Stock Price, Quote, News & History

NUVBNYSE

Trade with Public

Trade with Public

$4.55

0.071.56%

Last update: Oct 20, 9:20 AM

$4.55

0.071.56%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$4.49

Close

-

Volume / Avg.

726.28K / 5.55M

Day Range

$4.46 - $4.65

52 Wk Range

3.36 - 9.75

Market Cap

$1.60B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

31

Short Interest

27.61%

Days to Cover

13.88

Recent Nuvation Bio Inc. News

This Ciena Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated coverage: Buy on FORM ($200), NUVB ($12); Outperform on CIEN ($440); Neutral on EXPD ($180); Equal-Weight on SFD ($22).

Avi Kapoor

Why Is Nuvation Bio Stock Gaining Thursday?

Nuvation Bio (NUVB) stock jumps 6% after early FDA label update for IBTROZI, highlighting over 4 years of clinical benefit in ROS1+ NSCLC.

Vandana Singh

Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is...

Cramer calls Nuvation Bio a pure spec, prefers CoreWeave over IREN, is unsure on Seneca, cautious on NuScale, and approves Box.

Avi Kapoor

This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Wall Street analysts changed ratings for top stocks. See full list at Benzinga's analyst ratings page. TER, TX and more.

Avi Kapoor

This Equifax Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Wall Street analysts upgraded Parsons Corp, InnovAge Holding Corp, Equifax Inc, and initiated coverage on Builders FirstSource, Inc and Nuvation Bio Inc.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-120.52M

Investing Cash Flow (TTM)

-47.18M

Financing Cash Flow (TTM)

179.14M

Free Cash Flow (TTM)

-128.93M

Capital Expenditure (TTM)

-8.40M

Net Change in Cash (TTM)

11.43M

Analyst Trends and Forecast

3

May

4

Jul

3

Aug

2

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.16B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

9.12

PB Ratio (TTM)

6.20

Earnings Yield % (TTM)

-9.82%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.72

Company Debt

Total Debt

$248.52M

LT Debt

$242.62M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$258.60M

Debt to Equity

0.99

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$69.89M